Law ❯ Litigation ❯ Class Action ❯ Securities Fraud

False Statements

ImmunityBio Files FDA Response on Anktiva Ads as Investor Suits Build

The case centers on whether Anktiva promotions overstated benefits.

BellRing Investors Urged to Seek Lead-Plaintiff Status as March 23 Deadline Nears

Law Firms Seek Lead Plaintiffs in Ramaco Securities Case Over Brook Mine Disclosures

Vistagen Investors Urged to Seek Lead Plaintiff Role in Securities Suit as March 16 Deadline Nears

Inspire Medical Faces Securities Class Action Over Inspire V Rollout as Lead‑Plaintiff Deadline Nears

MoonLake Immunotherapeutics Investors Face Lead‑Plaintiff Deadline in Securities Fraud Suits

CarMax Securities Class Period Extended to Nov. 5 as Firms Press Jan. 2 Lead-Plaintiff Deadline